E Baysal

Author PubWeight™ 33.22‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 ICSH recommendations for the measurement of haemoglobin A2. Int J Lab Hematol 2011 2.23
2 The molecular basis of Hb H disease in Turkey. Hemoglobin 1997 1.24
3 Sickle cell membranes and oxidative damage. Biochem J 1986 1.20
4 alpha-thalassemia in the United Arab Emirates. Acta Haematol 1998 1.15
5 Inhibition of hemin-induced hemolysis by desferrioxamine: binding of hemin to red cell membranes and the effects of alteration of membrane sulfhydryl groups. Biochim Biophys Acta 1992 1.06
6 Hb Adana or alpha 2(59)(E8)Gly-->Asp beta 2, a severely unstable alpha 1-globin variant, observed in combination with the -(alpha)20.5 Kb alpha-thal-1 deletion in two Turkish patients. Am J Hematol 1993 1.02
7 Hb H disease in a Turkish family resulting from the interaction of a deletional alpha-thalassaemia-1 and a newly discovered poly A mutation. Br J Haematol 1992 0.99
8 Molecular characterization of Hb S(C) beta-thalassemia in American blacks. Am J Hematol 1991 0.98
9 A mild type of Hb S-beta(+)-thalassemia [-92(C-->T)] in a Sicilian family. Am J Hematol 1993 0.92
10 Molecular characterization of alpha-thalassemia determinants, beta-thalassemia alleles, and beta S haplotypes among Kuwaiti Arabs. Acta Haematol 1994 0.92
11 Types of thalassemia among patients attending a large university clinic in Kuala Lumpur, Malaysia. Hemoglobin 1992 0.90
12 Polymorphic pattern of the (AT)X(T)Y motif at -530 5' to the beta-globin gene in over 40 patients homozygous for various beta-thalassemia mutations. Am J Hematol 1994 0.89
13 The relative levels of alpha 2-, alpha 1-, and zeta-mRNA in HB H patients with different deletional and nondeletional alpha-thalassemia determinants. Biochim Biophys Acta 1996 0.88
14 A novel beta zero-thalassaemia mutation (codon 15, TGG----TGA) is prevalent in a population of central Portugal. Br J Haematol 1992 0.87
15 A novel deletion of approximately 27 kb including the beta-globin gene and the locus control region 3'HS-1 regulatory sequence: beta zero-thalassemia or hereditary persistence of fetal hemoglobin? Blood 1994 0.86
16 t-butyl hydroperoxide-induced perturbations of human erythrocytes as a model for oxidant stress. Biochim Biophys Acta 1985 0.85
17 Radio-protective effects of Nigella sativa oil on oxidative stress in tongue tissue of rats. Oral Dis 2013 0.84
18 Iron-mediated oxidative stress in erythrocytes. Biochem J 1987 0.84
19 Oxidative effects of iron on erythrocytes. Free Radic Res Commun 1985 0.83
20 Molecular characterization of beta-thalassemia in Azerbaijan. Hum Genet 1992 0.81
21 A large beta-thalassemia deletion in a family of Indonesian-Malay descent. Hemoglobin 1996 0.81
22 Assessment of the ear and otoacoustic emission findings in fibromyalgia syndrome. Clin Exp Rheumatol 2005 0.81
23 Sickle cell anemia, sickle cell beta-thalassemia, and thalassemia major in Albania: characterization of mutations. Hum Genet 1994 0.80
24 A de novo deletion causing epsilon gamma delta beta-thalassemia in a Dutch patient. Acta Haematol 1996 0.80
25 Genotype-phenotype correlation of sickle cell disease in the United Arab Emirates. Pediatr Hematol Oncol 1998 0.80
26 Beta-thalassemia mutations in the Portuguese; high frequencies of two alleles in restricted populations. Hemoglobin 1993 0.79
27 Management of incus long process defects: incus interposition versus incudostapedial rebridging with bone cement. J Laryngol Otol 2013 0.79
28 Possible factors influencing the haemoglobin and fetal haemoglobin levels in patients with beta-thalassaemia due to a homozygosity for the IVS-I-6 (T-->C) mutation. Br J Haematol 1994 0.79
29 Compound heterozygosity for a beta zero-thalassemia (frameshift codons 38/39; -C) and a nondeletional Swiss type of HPFH (A----C at NT -110, G gamma) in a Czechoslovakian family. Ann Hematol 1991 0.78
30 Hb H disease caused by a homozygosity for the AATAAA-->AATAAG mutation in the polyadenylation site of the alpha 2-globin gene: hematological observations. Acta Haematol 1992 0.78
31 Hb Costa Rica or alpha 2 beta 2 77(EF1)His --> Arg: the first example of a somatic cell mutation in a globin gene. Hum Genet 1996 0.78
32 The interactions of desferrioxamine and hydroxypyridone compounds with haemoglobin and erythrocytes. FEBS Lett 1989 0.77
33 Hb Coimbra or alpha 2 beta (2)99(G1)Asp----Glu, a newly discovered highoxygen affinity variant. Hemoglobin 1991 0.77
34 A Canadian family with Hb Wayne; characterization by HPLC and DNA sequencing. Hemoglobin 1992 0.77
35 Rare beta-thalassemia mutation IVS-II-848 (C-A) first reported in a Turkish Cypriot family. Am J Hematol 1997 0.77
36 Role of methylprednisolone in the prevention of postpericardiotomy syndrome after cardiac surgery. Eur Rev Med Pharmacol Sci 2016 0.77
37 ICSH recommendations for the measurement of haemoglobin F. Int J Lab Hematol 2011 0.76
38 Beta-thalassemia alleles and unstable hemoglobin types among Russian pediatric patients. Am J Hematol 1994 0.76
39 Alpha-Thalassemia and fetal hemoglobin. Blood 1994 0.76
40 The unstable Hb Hammersmith or alpha 2 beta 2(42)(CD1)Phe----Ser observed in an Indian child; identification by HPLC and by sequence analysis of amplified DNA. Hemoglobin 1992 0.75
41 The role of high frequency tympanometry in newborn hearing screening programme. Eur Rev Med Pharmacol Sci 2012 0.75
42 An IVS-I-117 (G-->A) acceptor splice site mutation in the alpha 1-globin gene is a nondeletional alpha-thalassaemia-2 determinant in an Indian population. Br J Haematol 1993 0.75
43 The T-->C mutation at position +96 of the untranslated region 3' to the terminating codon of the beta-globin gene is a rare polymorphism that does not cause a beta-thalassemia as previously ascribed. Hum Genet 1994 0.75
44 A Czechoslovakian teenager with Hb E-beta zero-thalassemia [IVS-I-1 (G----A)] complicated by the presence of an alpha-globin gene triplication. Ann Hematol 1991 0.75
45 Black beta-thalassemia homozygotes with specific sequence variations in the 5' hypersensitive site-2 of the locus control region have high levels of fetal hemoglobin. Am J Hematol 1992 0.75
46 Factors associated with hypochromia and microcytosis among high school students in the southeastern United States. South Med J 1994 0.75
47 Hb Bibba or alpha 2 136(H19)Leu-->Pro beta 2 in a Caucasian family from Alabama. Hemoglobin 1995 0.75
48 Role of membrane-bound haemoglobin products in oxidative damage in sickle cell membranes. Acta Haematol 1987 0.75
49 Thalassemia intermedia in two patients with Hb Lepore-beta zero-thalassemia (Frameshift codon 8, -AA). Hemoglobin 1994 0.75
50 Needle in the heart. Herz 2013 0.75
51 Value of the neutrophil-to-lymphocyte ratio in predicting post-pericardiotomy syndrome after cardiac surgery. Eur Rev Med Pharmacol Sci 2016 0.75
52 Quantities of alpha Q chain variants in heterozygotes with and without a concomitant beta-thalassemia trait. Am J Hematol 1994 0.75
53 Hb Mizuho or alpha 2 beta (2)68(E12)Leu----Pro in a Caucasian boy with high levels of Hb F; identification by sequencing of amplified DNA. Hemoglobin 1991 0.75